| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| September 27th, 2005 | 23 | Yes |
Popular Name: Methotrimeprazine Methotrimeprazine
(-)-10-(3-[DIMETHYLAMINO]-2-METHYLPROPYL)-2-METHOXY-PHENOTHIAZINE MALEATE SALT
2-methoxy-10-(2-methyl-3-dimethylaminopropyl)phenothiazine
60-99-1; C07192; Levomepromazine; Methotrimeprazine
60-99-1; Methotrimeprazine maleat salt; Prestwick_1008
7104-38-3; D02248; Hirnamin (TN); Levomepromazine maleate (JP16/USAN)
CL-36467; CL-39743; RP-7044; SK&F-5116; XP03
FDA); Methotrimeprazine (USP); Levomepromazine Maleate (JAN
levomepromazina; levomepromazine; levomepromazinum
USAN); Levomepromazine HCl (JAN
USAN); Methotrimeprazine (USP); Levomepromazine Hcl (USAN)
USAN); Methotrimeprazine (USP); Levomepromazine Maleate (JAN
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 4.89 | 11 | -40.69 | 1 | 3 | 1 | 19 | 329.489 | 5 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 5.25e-03 g/l | DrugBank-approved |
| PUBCHEM_PATENT_ID | EP0000306A1; EP0174342A1; EP0215313B1; EP0216936A1; EP0315079A1; EP0315079B1; EP0418386A1; EP0418386B1; EP0427396A2; EP0427396B1; EP0493513B1; EP0556394A1; EP0617618A1; EP0637448A1; EP0665009A1; EP0665009B1; EP0705298A1; EP0797424A1; EP0797424B1; EP090610 | IBM Patent Data |
| Patent Database Links | EP1627639; EP1938803; US2005080075; WO2007112581; WO2008116308 | ChEBI |
